Sign inGet started

Levine Mitchell S

Insider CIK 1383492 · OCX Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
OCX Oncocyte Corp A Award deriv2022-03-152022-03-1787,500— $087,500SEC↗
OCX Oncocyte Corp A Award deriv2022-03-152022-03-1787,500— $087,500SEC↗
OCX Oncocyte Corp P Buy2022-03-152022-03-1525,000$1.17 $29.3K87,080SEC↗
OCX OncoCyte Corp M Exercise deriv2021-04-282021-04-3020,000— $00SEC↗
OCX OncoCyte Corp M Exercise2021-04-282021-04-3020,000— $066,700SEC↗
OCX OncoCyte Corp F Tax w/h2021-04-282021-04-304,620— $062,080SEC↗
OCX OncoCyte Corp A Award deriv2021-02-252021-03-01255,000$5.34 $1.36M255,000SEC↗
OCX OncoCyte Corp A Award2020-12-112020-12-1510,121— $046,700SEC↗
OCX OncoCyte Corp P Buy2020-09-122020-12-1510,000$2.01 $20.1K13,495SEC↗
OCX OncoCyte Corp P Buy2020-08-032020-08-0410,000$1.32 $13.2K36,579SEC↗
OCX OncoCyte Corp A Award deriv2020-04-282020-04-3020,000— $020,000SEC↗
OCX OncoCyte Corp A Award deriv2020-04-282020-04-3020,000— $020,000SEC↗
OCX OncoCyte Corp M Exercise deriv2020-03-142020-04-2020,000— $00SEC↗
OCX OncoCyte Corp F Tax w/h2020-03-142020-04-206,916— $026,579SEC↗
OCX OncoCyte Corp M Exercise2020-03-142020-04-2020,000— $033,495SEC↗
OCX Oncocyte Corp A Award deriv2020-02-102020-02-12204,000— $0204,000SEC↗
OCX OncoCyte Corp P Buy2019-09-122020-12-1710,000$2.01 $20.1K13,495SEC↗
OCX OncoCyte Corp P Buy2019-09-122019-09-1210,000$2.01 $20.1K10,000SEC↗
OCX OncoCyte Corp A Award deriv2019-03-142019-03-1820,000— $020,000SEC↗
OCX OncoCyte Corp A Award deriv2019-03-142019-03-18245,000— $0245,000SEC↗
OCX OncoCyte Corp P Buy deriv2018-07-262018-07-313,495— $03,495SEC↗
OCX OncoCyte Corp P Buy2018-07-262018-07-313,495— $03,495SEC↗
OCX OncoCyte Corp A Award deriv2018-06-132018-06-1545,000— $045,000SEC↗
OCX OncoCyte Corp A Award deriv2018-05-232018-06-01125,000— $0125,000SEC↗
OCX OncoCyte Corp A Award deriv2018-05-232018-06-0150,000— $050,000SEC↗
OCX OncoCyte Corp A Award deriv2017-11-152017-11-17200,000— $0200,000SEC↗